Affordability

Best Tirzepatide Telehealth Program 2026: The 5 Traps and the One That Avoids Them All

Pricing current as of September 15, 2026
Every price in this guide was pulled from each provider’s own site or from independent third-party rankings on September 15, 2026. Advertised prices in this category change frequently — sometimes weekly. Verify the current rate on each provider’s site before signing up. This is educational information, not medical or financial advice. Individual results vary. SkinnyVIP is included on this list; we say so up front, and we hold ourselves to the same criteria we use on every other program.

The 5 traps every tirzepatide telehealth patient walks into

You typed “best telehealth tirzepatide” into Google. You want the program that won’t screw you over. So let’s cut to it. Every telehealth tirzepatide provider we’re about to compare pulls at least one of these moves. SkinnyVIP is the only one on this list that pulls none of them.

  1. The introductory price trap. A shiny $89 or $149 headline on the homepage. Then, after the promo window, the price jumps to $249, $279, or $299 — often with a card already on file and a subscription already running.
  2. The hidden membership trap. “As low as $90/month” on the landing page, then $79/month membership added at checkout. Your real monthly cost is $169+, not $90.
  3. The 45-day refill trap. Brand-name Zepbound at $449/month for a maintenance dose — but only if you refill within 45 days. Miss the window by three days on a trip and the same medication costs you $699. That’s a $250/month penalty for having a life.
  4. The dose-escalator trap. Price goes up every time your clinician titrates you. You start at $199/month at 2.5 mg. By 10 mg maintenance you’re at $399/month. Nobody warned you that the price ladder existed until you were already climbing it.
  5. The auto-renewal trap. You paid for “3 months.” Month four, your card gets charged again automatically. You didn’t cancel because you didn’t know you had to.

Below is every program a patient realistically considers in 2026, mapped to which of the five traps each one pulls. Then, at the end, SkinnyVIP — the one that pulls zero of them. Every price was pulled from each provider’s own site on September 15, 2026. Advertised prices in this category change frequently. Compounded medications are prepared by licensed compounding pharmacies under physician supervision. Compounded medications are not FDA-approved products. Individual results vary. A licensed clinician reviews each patient’s health history to determine whether treatment is appropriate; prescription is not guaranteed.

The trap map at a glance

Provider Intro rate
trap
Hidden
membership
45-day
refill trap
Dose
escalator
Auto-
renewal
AltRx Yes No No No Yes
Mochi Health No Yes No Yes Yes
Ro Body No Yes Yes Yes Yes
LillyDirect No No Yes Yes No
Amble Health No No No Yes Yes
Henry Meds No No No No Yes
SkinnyVIP No No No No No

Prices and program terms verified September 15, 2026 from provider sites and independent third-party rankings. Compounded medications are not FDA-approved products.

The pattern
Every other program pulls at least one trap. SkinnyVIP pulls none.

The details on each program below. If you already know what you want, jump to the SkinnyVIP breakdown.

AltRx — the $149 headline that becomes $299

Trap pulled: Introductory price trap + auto-renewal.

AltRx runs one of the loudest “$149/month” headlines in the category. That’s the introductory rate. The standard rate published on their own site is $299/month for tirzepatide. So a patient who signs up expecting $149/month can find herself locked into a subscription that’s double the sticker within a few months, with her card already on file.

The $149 rate is real. The $299 standard rate is also real. Which one you actually pay depends on the fine print of when the promo ends. If you sign up on the intro rate and want to leave, that’s a cancellation you have to actively initiate — there is no natural end date. This is the pattern the low-headline market has trained a whole generation of patients to expect. AltRx’s own pricing page is where you verify current terms before entering a card.

Mochi Health — the “$90” that’s actually $169

Traps pulled: Hidden membership + dose escalator + auto-renewal.

Mochi’s homepage promises tirzepatide “as low as $90/month.” What the homepage does not tell you is that a Mochi membership — separate from the medication — runs $39 the first month promotional, then $79/month thereafter. The published floor a real patient can compute before signing up is $129 the first month, $169 per month ongoing. The published upper bound isn’t on the homepage at all — you find out what your dose costs during intake.

Then the dose escalator kicks in. “As low as $90” means the starter dose. As your clinician titrates you up, the medication price climbs, and the membership stays. And the membership auto-renews. Our full Mochi Health teardown walks through every price wall in detail.

Ro Body — brand-name Zepbound with three separate walls

Traps pulled: Hidden membership + 45-day refill trap + dose escalator + auto-renewal.

Ro Body sells brand-name Zepbound at Eli Lilly’s self-pay prices: $299 for 2.5 mg, $399 for 5 mg, $449 for 7.5 to 15 mg. That’s only true if you refill within 45 days. Miss the window and the same maintenance dose jumps to $499–$699/month. That’s a $250/month penalty for a scheduling slip. Ro then adds its own Ro Body membership on top of the medication, roughly $74–$149/month. And the whole thing auto-renews.

Ro Body is the correct choice for a patient who specifically wants brand-name FDA-approved Zepbound and can hit every 45-day refill window perfectly. For most people, that’s three walls stacked on the same box.

LillyDirect — brand-name Zepbound at Lilly’s own prices

Traps pulled: 45-day refill trap + dose escalator.

LillyDirect is the manufacturer-direct option: $299 for 2.5 mg, $399 for 5 mg, $449 for 7.5 through 15 mg — when you refill within the 45-day window. Miss it and the same 10 mg dose becomes $699/month. LillyDirect doesn’t layer a separate membership fee, which is cleaner than Ro Body, but the 45-day trap and the dose escalator are still there.

LillyDirect is right if you want brand-name Zepbound, don’t need a clinical care wrapper, and have iron-clad refill scheduling. Verify current terms on Zepbound’s official self-pay page before you sign up.

Amble Health — two-band dose escalator

Traps pulled: Dose escalator + auto-renewal.

Amble prices tirzepatide in two bands: $289/month for 2.5–5 mg, $329/month for 7.5–15 mg. A two-band ladder is flatter than most competitors and Amble does publish it up front, which is genuinely useful. Multi-month prepay drops the effective monthly rate. There is no separate membership fee.

The catch: the dose does climb the ladder, and the multi-month plans auto-renew unless you cancel. So a patient who titrates from 5 mg to 7.5 mg mid-plan gets a $40/month increase without expecting one. Not the worst trap on this list — but still a trap.

Henry Meds — the “established brand” tax

Traps pulled: Auto-renewal.

Henry Meds is the least trap-loaded competitor on this list. No introductory bait-and-switch. No separate membership. No 45-day refill window. No dose escalator. Just $399 the first month, then $449/month ongoing. The trap is a different one: you’re paying roughly $200/month more than SkinnyVIP’s effective rate for compounded tirzepatide, and the subscription still renews automatically until you cancel.

Henry is fine if you want the longest-running brand in this space and price isn’t your top concern. If it is, you’re paying $2,400 more per year than you need to. Our full Henry Meds teardown walks through the math.

SkinnyVIP — the one that pulls zero traps

Traps pulled: None.

SkinnyVIP charges $695 for a 3-month plan (about $232/month effective) or $350 for a single month. That’s not the lowest sticker price on this list — AltRx’s $149 introductory rate is lower on the headline. But look at what $232/month actually gets you and what it doesn’t make you sign up for:

Every trap avoided
  • No introductory bait pricing that jumps later
  • No membership fee stacked on the medication
  • No 45-day refill window that triples your bill
  • No dose escalator — same price at 2.5 mg or 15 mg
  • No auto-renewal — when your plan ends, it ends
  • No insurance paperwork required

The 3-month plan is $695 upfront. You know the total before you enter a card. Your dose can climb from 2.5 mg to 15 mg over those three months and the price does not change. When month three ends, nothing renews. If you want a fourth month, you buy it. If you don’t, nothing charges your card.

SkinnyVIP is a physician-founded, physician-led telehealth practice. A licensed clinician reviews each patient’s health history and determines whether treatment is appropriate; prescription is not guaranteed. SkinnyVIP does not itself prescribe. Compounded medications are prepared by licensed compounding pharmacies under physician supervision. Compounded medications are not FDA-approved products. Individual results vary. Not affiliated with Novo Nordisk (Ozempic®/Wegovy®) or Eli Lilly (Mounjaro®/Zepbound®).

If you want the deeper clinical breakdown, our $232/month compounded tirzepatide overview walks through what’s included. If you want the full pricing math against every provider we didn’t rank here, the 2026 compounded GLP-1 telehealth pricing comparison covers 10+ additional programs. For fresh news on brand-name Zepbound coverage returning to CVS Caremark, see the CVS Caremark October 1 formulary change.

The zero-trap option

$695 for a 3-month plan (about $232/month) or $350 for a single month. Any dose, no membership, no auto-renewal, no refill trap, no dose escalator. You know the total before you enter a card.

Learn About Tirzepatide See Pricing

Compounded medications are not FDA-approved products. Individual results vary. A licensed clinician reviews each patient; prescription is not guaranteed.

Keep Reading

Sources

  1. AltRx. Compounded GLP-1 / GIP $149/mo pricing page. AltRx official pricing page (verified September 15, 2026)
  2. U.S. News & World Report. AltRx GLP-1s Review 2026. U.S. News independent AltRx review
  3. Amble Health. Compounded GLP-1 injections pricing. Amble Health official plans page (verified September 15, 2026)
  4. Eli Lilly. Zepbound (tirzepatide) KwikPen now available at self-pay pricing starting at $299/month. March 13, 2026. Eli Lilly investor relations statement
  5. Eli Lilly. Zepbound Coverage, Affordability, and Savings (Self Pay Journey Program). Zepbound official self-pay page
  6. Ro Body. Zepbound program pricing. Cross-verified via Formblends Ro Zepbound cost breakdown (September 2026)
  7. U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA compounding policy
Frequently Asked Questions

The 5 Traps FAQ

Five questions that expose the fine print on the programs above.

Why does the AltRx $149 headline become $299 later?

The $149 monthly price advertised on AltRx is the introductory rate. AltRx’s own site lists $299 per month as the standard rate for compounded tirzepatide. New patients who sign up expecting $149 per month can find themselves paying the standard $299 rate once the promotional window ends, with a card already on file and a subscription already running. Verify current terms directly on AltRx’s own pricing page before entering a card. SkinnyVIP does not use introductory pricing: $695 for a 3-month plan (about $232 per month effective) or $350 for a single month is the full published price.

Why is the Mochi “as low as $90” price actually $169 per month?

Mochi Health’s headline is medication-only. A separate Mochi membership runs $39 the first month (promotional) then $79 per month thereafter, on top of the medication cost. The published floor a new patient can compute before signing up is $129 the first month and $169 per month ongoing. Higher doses cost more than $90 per month for the medication, and the membership stays whatever dose you are on. SkinnyVIP does not charge a separate membership fee: the $232 per month effective rate on a 3-month plan is the full cost of consultation, medication, supplies, and shipping.

What is the 45-day refill trap on brand-name Zepbound?

Both LillyDirect and Ro Body sell brand-name Zepbound at $299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5 to 15 mg per month — but only if you refill within 45 days of your previous fill. Miss the 45-day window and the same maintenance dose costs $499 to $699 per month. That is a $250 per month penalty for a scheduling slip. This applies to brand-name Zepbound through LillyDirect and Ro Body. Compounded tirzepatide programs generally do not carry a 45-day refill window because refill cadence is set by the practice and pharmacy, not the manufacturer.

Do all telehealth tirzepatide providers charge more as the dose goes up?

Most do. LillyDirect and Ro Body price by dose. Amble Health prices in two bands. Mochi Health prices medication by dose above the “as low as $90” starter. AltRx and Henry Meds hold price flat across doses. SkinnyVIP holds the same $232 per month effective rate (on the 3-month plan) or $350 per month (single month) from 2.5 mg all the way up to 15 mg — titration does not change what you pay.

Which telehealth tirzepatide program has no auto-renewal?

SkinnyVIP is the only program on this comparison that operates on discrete plans that do not auto-renew. When your 3-month plan or 1-month plan ends, nothing charges your card again. You buy the next plan when you want it, or you don’t. AltRx, Mochi, Ro Body, Amble Health, and Henry Meds each operate as subscriptions or memberships that continue billing until you actively cancel. Compounded medications are prepared by licensed compounding pharmacies under physician supervision. Compounded medications are not FDA-approved products. A licensed clinician reviews each patient; prescription is not guaranteed. SkinnyVIP does not itself prescribe. Individual results vary. Not affiliated with Novo Nordisk (Ozempic®/Wegovy®) or Eli Lilly (Mounjaro®/Zepbound®).

This content is for informational purposes only and is not medical advice, legal advice, or insurance advice. Open-enrollment windows, plan coverage rules, formulary tier placements, prior-authorization criteria, and manufacturer pricing programs vary and change frequently; confirm current terms with your own HR team, insurer, licensed clinician, pharmacy benefit manager, and state regulators before acting. Not affiliated with Novo Nordisk (Ozempic®/Wegovy®) or Eli Lilly (Mounjaro®/Zepbound®). Compounded medications are prepared by licensed compounding pharmacies under physician supervision. Compounded medications are not FDA-approved products. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. A licensed clinician reviews each patient; prescription is not guaranteed. Individual results vary. SkinnyVIP does not itself prescribe.